Premium
α‐Glucosidase inhibitor acarbose and sequestome 1/A170/p62 deficient mice: A promising therapy and unique model for non‐alcoholic fatty liver disease
Author(s) -
Uto Hirofumi
Publication year - 2009
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/j.1872-034x.2009.00585.x
Subject(s) - hepatology , steatohepatitis , fatty liver , medicine , gastroenterology , acarbose , disease , family medicine , gerontology , endocrinology , diabetes mellitus